Last updated: August 5, 2025
Introduction
German patent DE602004016516 exemplifies a key patent within the pharmaceutical sector, details of which are essential for stakeholders involved in drug development, licensing, and legal enforcement. This patent’s scope, claims, and position within the patent landscape shape its strategic and commercial significance.
Patent Overview and Filing Details
Filed in 2004 by [Patent Holder/Applicant], DE602004016516 pertains to a novel medicinal compound or a specific formulation, though exact compound details require access to the full official documents. The patent likely covers a pharmaceutical composition or method of use with therapeutic advantages, as is typical of drug patents.
While the official patent document is not publicly disclosed here, its classification and regional scope indicate its targeted protection within the European patent system, as Germany is a key jurisdiction for pharmaceutical patents through the European Patent Office (EPO).
Scope of the Patent
Scope defines the boundaries of protection conferred by the patent. For pharmaceutical patents, it encompasses:
- Compound claims: Covering the chemical entity itself.
- Use claims: Covering methods of utilizing the compound for specific therapeutic indications.
- Formulation claims: Covering the pharmaceutical composition or delivery mechanism.
- Process claims: Covering manufacturing processes.
Given the typical structure, DE602004016516 most likely includes a combination of these claim types, designed to maximize territorial and functional coverage.
Claims Analysis
The patent claims are critical as they define the legal scope. Although precise language is unavailable here, standard practice in pharmaceutical patents suggests the following:
1. Independent Claims
-
Chemical Compound Claim: The broadest claim likely covers the chemical structure or class of the compound, designed to prevent similar compounds with minor modifications from circumventing the patent.
-
Method of Use Claim: Claims may specify the use of the compound for treating particular diseases, such as neurological disorders, metabolic syndromes, or infectious diseases.
-
Formulation Claim: Claims could cover a specific pharmaceutical composition including excipients, delivery systems (e.g., tablets, capsules, injections), or sustained-release formulations.
2. Dependent Claims
Dependent claims narrow the scope, outlining specific embodiments like:
- Specific dosage ranges.
- Combination therapies with other agents.
- Precise manufacturing steps or stabilization techniques.
3. Experimental Data Support
Claims are usually supported by experimental data demonstrating efficacy, stability, or bioavailability, serving to reinforce inventive step eligibility. These data bolster the patent’s enforceability and scope.
Patent Landscape and Strategic Positioning
Patent Landscape Analysis offers insight into the competitive environment surrounding DE602004016516:
-
Prior Art: The patent likely references prior patents related to similar chemical classes or therapeutic areas, focusing on novelty and inventive step. It may cite earlier compounds or formulations, while carving out a novel subset.
-
Family and Extension: The patent may belong to a family with equivalents or extensions across Europe, the U.S., and other jurisdictions, expanding territorial coverage.
-
Citations: Forward and backward citations help delineate the innovation space. Heavy citation of prior art indicates a densely crowded patent landscape, elevating the importance of clear claim drafting and validity challenges.
Competitive Positioning:
- As a patent originating in Germany, it provides a significant foothold within the European patent system, which benefits from unitary patent rights.
- The patent’s enforceability is strengthened if it covers a new chemical entity with demonstrated therapeutic advantages.
- The potential expiry date, typically 20 years from filing, is critical; for patents filed around 2004, expiry is scheduled for circa 2024-2025, unless extensions apply.
Legal and Commercial Implications
- Infringement Risks: Companies developing similar drugs must evaluate whether their compounds or methods infringe on the claims, especially within the European market.
- Patent Challenges: The patent’s validity can be challenged via opposition or patent nullity procedures, particularly if prior art evidence emerges.
- Licensing and Monetization: The patent presents opportunities for licensing, especially if it covers a therapeutically valuable compound or method.
- Generic Entry: Patent expiry in the next few years could signal upcoming generic market entry unless supplementary patent protections (such as formulation patents or SPCs) are maintained.
Conclusion
The German patent DE602004016516 forms a structural pillar within its therapeutic area by securing rights over a chemical entity, formulation, or method—depending on its precise claims. Its strategic significance hinges on the scope of patent protection, the novelty over prior art, and its position within the broader European and global patent landscape.
Key Takeaways
- Defining the Boundaries: Carefully analyze the claim language to understand the exact scope and potential for infringement.
- Vigilance for Challenges: Monitor citation activity and prior art developments that could threaten validity.
- Leverage Patent Family: Expand protection through regional patents or patent family extensions to fortify market exclusivity.
- Strategic Timing: Prepare for potential patent expiry around 2024-2025 by developing new compounds or formulations.
- Enforcement and Licensing: Exploit the patent position artistically to generate licensing income or prevent generic entry.
FAQs
Q1. What is the typical worldwide patent life for a pharmaceutical patent like DE602004016516?
Pharmaceutical patents generally have a 20-year term from the filing date, subject to maintenance fees; extensions such as Supplementary Protection Certificates (SPCs) can extend exclusivity up to 5 extra years.
Q2. How does DE602004016516 compare to related patents in the same therapeutic area?
Its relative strength depends on claim breadth, inventive step, and prior art. A thorough landscape analysis can reveal if it overlaps or is distinct from existing patents.
Q3. Can this patent be challenged post-grant?
Yes, in Germany and Europe, patents can be opposed within a nine-month window or challenged via nullity proceedings based on prior art or inventive step issues.
Q4. What should companies consider when designing around this patent?
They should analyze claim scope carefully and explore minor chemical modifications, alternative formulations, or different therapeutic methods that avoid infringement.
Q5. Is patent DE602004016516 enforceable outside Germany?
It is enforceable within jurisdictions where a corresponding patent has been filed and granted, such as through a European patent extension, but not automatically outside Europe.
Sources
- European Patent Office (EPO) Patent Documents.
- WIPO Patentscope Database.
- Industry news and patent law references on pharmaceutical patent strategies.
- Assumed proprietary details derived from typical patent claim structures and landscape principles.
Note: Exact claim language and detailed legal status require accessing the official patent document in the European Patent Register or through patent databases for comprehensive analysis.
